Therapeutic Area Experience
We lead the field in using oxygen as a contrast agent for lung MRI to provide quantitative imaging-based regional measurements of gas delivery. We are also leaders in the use of conventional contrast agents to assess lung perfusion and microvascular function and provide MRI-based measurements of lung mechanics.
The Bioxydyn team has expertise in MRI methods for quantifying tumour oxygen delivery, vascular status and cellularity. By providing unique non-invasive information our technologies can aid tumour characterisation and therapeutic decision making.
Effective neurological MRI is essential for monitoring disease progression and response to intervention. Our expertise in the delivery of advanced quantitative MRI methods provides quantitative measurements of the impact of disease and treatment on tissue characteristics and function.
We monitor the vascular status, morphology and microstructure of inflamed tissue through the course of disease and treatment. We provide high sensitivity quantitative non-invasive MRI measurements for monitoring inflamed joints and other organs, including the lung.